Navigation Links
Coated Stents Better Than Bare Metal Ones in Short Run
Date:12/18/2008

But slightly higher mortality rates showed up after 3 years, study finds

THURSDAY, Dec. 18 (HealthDay News) -- Angioplasty patients who receive stents coated with medication to prevent narrowing of the artery do better one year after the surgery than those who receive bare metal stents, a new study shows.

However, within three years of the procedure, patients with these drug-eluting stents (DES) face a greater risk of more surgery to increase blood flow or even death, according to the study of 6,440 patients, expected to be published in the Jan. 20 issue of CMAJ.

"Despite recent concerns surrounding drug-eluting stent safety, the long-term survival [to three years] of patients receiving drug-eluting stents remains globally favorable and certainly not measurably worse than that of patients treated with bare metal stents," study co-authors Drs. William Ghali and Andrew Philpott of the University of Calgary, said in a journal news release. "However, we did observe a concerning risk trend toward accelerating adverse events in the DES group late in the follow-up period -- a finding that underlines the need for ongoing surveillance of longer-term outcomes."

The study found that the death rate for people with drug-eluting stents was significantly lower than for those with bare metal stents in the first 30 days after the operation. It also noted that DES patients tended to be women and also had higher rates of kidney disease, diabetes, high cholesterol and hypertension.

In a related commentary to be published on the journal's Web site later this week, Columbia University Medical Center Drs. Philippe Généreux and Roxana Mehran wrote that, despite increasing positive study results about drug-eluting stents, their long-term safety is still a concern, citing particular concerns about the development of stent thrombosis.

More information

The U.S. Food and Drug Administration has more about drug-eluting stents.



-- Kevin McKeever



SOURCE: CMAJ, news release, Dec. 18, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Drug-Coated Stents Go Head to Head
2. Study Finds Benefits With Drug-Coated Stents
3. New Canadian study finds drug coated heart stents to be safe:
4. Starpharma and Durex Sign Co-Development Agreement for VivaGel(R)-Coated Condoms
5. Drug-Coated Stents No Riskier in Long Run Than Bare Metal Ones
6. Study Finds Both Coated Stents Perform the Same
7. Drug-Coated Stents Better Than Bare-Metal Ones in Complex Cases
8. Drug-Coated Balloons Keep Leg Arteries Open: Study
9. Drug-coated balloon overcomes in-stent restenosis
10. New Drug-Coated Stent Does Well in Early Trial
11. Perrigo Receives FDA Approval to Market Orange, Coated Nicotine Gum
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Coated Stents Better Than Bare Metal Ones in Short Run
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... DIEGO , Oct. 12, 2017 AVACEN ... recognized the company with their  2017 New Product Innovation Award ... based on extensive primary and secondary medical device market research ... Medical, through its first-to-market OTC, drug-free pain relief product, the ... unique approach to treating fibromyalgia widespread pain. ...
(Date:10/12/2017)... , Oct. 12, 2017 West Pharmaceutical ... innovative solutions for injectable drug administration, today announced that ... market opens on Thursday, October 26, 2017, and will ... and business expectations at 9:00 a.m. Eastern Time. To ... 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ... on fulfilling the promise of precision medicine, today announced ... joined Caris, Precision Oncology Alliance™ (POA) as its 17 ... centers, the St. Jude Crosson Cancer Institute will help ... the use of tumor profiling, making cancer treatment more ...
Breaking Medicine Technology: